Mixed fortunes for the appeal boards

Back in 2012, it would have been hard to envision the type of cases that would take centre stage at the US Patent Trial and Appeal Board (PTAB). As the board was introduced that year, with the newly-formed inter partes review (IPR) falling within its remit, Native American tribes and the question of sovereign immunity almost certainly crossed no-one’s mind.